-- 
TLG Capital Raises Stake in Ugandan HIV, Malaria Drugmaker

-- B y   C h r i s   K a y
-- 
2011-07-12T15:24:38Z

-- http://www.bloomberg.com/news/2011-07-12/tlg-capital-raises-stake-in-ugandan-hiv-malaria-drugmaker.html
TLG Capital, a private equity firm
focused on frontier markets, increased to 12.5 percent its
investment in Quality Chemicals Industries Ltd., a Ugandan
antiretroviral and anti-malarial drugmaker, the company said in
an e-mailed statement today.  To contact the reporter on this story:
Chris Kay in London at 
 ckay5@bloomberg.net   To contact the editor responsible for this story:
Gavin Serkin at 
 gserkin@bloomberg.net  